1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) is sponsored by NIH National Institute of Child Health and Human Development (NICHD). This funding opportunity aims to further elucidate the mechanisms of early immune development in utero, during the early post-natal period, and during early childhood in neonates, infants, and children and adolescents.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) Simpler. Grants. gov uses Login.
gov to verify your identity and manage your account securely. You don't need a separate username or password for this site. Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) Agency: National Institutes of Health Assistance Listings: 93.
865 -- Child Health and Human Development Extramural Research Last Updated: May 13, 2026 View version history on Grants.
gov The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART).
This initiative aims to understand intricate mechanisms of immune cells at the maternal-fetal interface, T and B cell development and maturation in offspring, and local immune responses and the role of systemic immunity.
Public and state institutions of higher education Independent school districts Private institutions of higher education For-profit organizations other than small businesses Nonprofits non-higher education with 501(c)(3) Other Native American tribal organizations Nonprofits non-higher education without 501(c)(3) Special district governments Federally recognized Native American tribal governments Public and Indian housing authorities City or township governments Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Grantor contact information See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. File name Description Last updated PAR-25-362-Full-Announcement.
html PAR-25-362 Full Announcement Text Dec 30, 2024 04:12 PM UTC Link to additional information https://grants. nih. gov/grants/guide/pa-files/PAR-25-362.
html Closing: November 5, 2028 Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Income security and social services Your account requires additional identity verification.
According to the current listing, eligibility includes: State governments, Native American tribal organizations (other than Federally recognized tribal governments), faith-based or community-based organizations, regional organizations, non-domestic (non-U. Confirm the full requirements in the official notice before applying.
Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) is funded by NIH National Institute of Child Health and Human Development (NICHD). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NICHD's FY2026 funding strategy applies an automatic 14 percent reduction to every new R01 below the peer-review recommended level, eliminates inflationary increases on future-year commitments, and abandons a fixed payline entirely in favor of priority-driven discretion. The structural implications for child health investigators.
Read articleThe Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read article